Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse

Evidence from two parallel in vitro mouse models

Joshua G. Yorgason, Gilda M. Kalinec, William M. Luxford, Frank M. Warren, Federico Kalinec

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: Acetaminophen/hydrocodone, a commonly used analgesic preparation, has been linked to rapidly progressing sensorineural hearing loss in human patients. The cellular and molecular mechanisms underlying the ototoxic effects of this drug combination are currently unknown, but are usually associated with high doses of hydrocodone. This study was aimed at identifying the specific agent responsible for hearing loss from toxic killing of cochlear sensory cells. Study Design: Dose-response study. Setting: University laboratory and private research facility. Subjects and Methods: Math1 green fluorescent protein neonatal mouse cochlear cultures as well as a mouse auditory cell line (HEI-OC1) were exposed in vitro to different concentrations of acetaminophen, hydromorphone (the active metabolite of hydrocodone), and the micronutrient L-carnitine, either alone or combined. Using fluorescent and light microscopy, we quantified the sensory hair cells from a 600-μm basal segment before and after treatment. Acetaminophen/hydrocodone-induced apoptosis of HEI-OC1 was evaluated by caspase 3-activation studies. Statistically significant cell survival was determined with Student t test and analysis of variance. Results: Cell death was associated mainly with exposure to acetaminophen, was slightly potentiated when combined with hydromorphone, and was partially prevented by L-carnitine. Exposure to hydrocodone or hydromorphone alone failed to kill either cochlear hair cells or HEI-OC1 cells. Conclusion: Our findings point to acetaminophen, rather than hydrocodone, as the primary cytotoxic agent. Hydrocodone, however, may work synergistically with acetaminophen, increasing the damage to auditory cells. These findings are an important first step toward understanding the mechanism of acetaminophen/hydrocodone ototoxicity and may lead to future treatment strategies for hearing loss from ototoxic medications.

Original languageEnglish (US)
JournalOtolaryngology - Head and Neck Surgery
Volume142
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Hydrocodone
Hydromorphone
Acetaminophen
Carnitine
Cochlea
Hearing Loss
Auditory Hair Cells
Sensorineural Hearing Loss
Micronutrients
Poisons
Cytotoxins
Drug Combinations
Green Fluorescent Proteins
Caspase 3
Analgesics
Microscopy
Cell Survival
Analysis of Variance
Cell Death
Apoptosis

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse : Evidence from two parallel in vitro mouse models. / Yorgason, Joshua G.; Kalinec, Gilda M.; Luxford, William M.; Warren, Frank M.; Kalinec, Federico.

In: Otolaryngology - Head and Neck Surgery, Vol. 142, No. 6, 06.2010.

Research output: Contribution to journalArticle

Yorgason, Joshua G. ; Kalinec, Gilda M. ; Luxford, William M. ; Warren, Frank M. ; Kalinec, Federico. / Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse : Evidence from two parallel in vitro mouse models. In: Otolaryngology - Head and Neck Surgery. 2010 ; Vol. 142, No. 6.
@article{7d50268de8e04a6687751a7e05430730,
title = "Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: Evidence from two parallel in vitro mouse models",
abstract = "Objective: Acetaminophen/hydrocodone, a commonly used analgesic preparation, has been linked to rapidly progressing sensorineural hearing loss in human patients. The cellular and molecular mechanisms underlying the ototoxic effects of this drug combination are currently unknown, but are usually associated with high doses of hydrocodone. This study was aimed at identifying the specific agent responsible for hearing loss from toxic killing of cochlear sensory cells. Study Design: Dose-response study. Setting: University laboratory and private research facility. Subjects and Methods: Math1 green fluorescent protein neonatal mouse cochlear cultures as well as a mouse auditory cell line (HEI-OC1) were exposed in vitro to different concentrations of acetaminophen, hydromorphone (the active metabolite of hydrocodone), and the micronutrient L-carnitine, either alone or combined. Using fluorescent and light microscopy, we quantified the sensory hair cells from a 600-μm basal segment before and after treatment. Acetaminophen/hydrocodone-induced apoptosis of HEI-OC1 was evaluated by caspase 3-activation studies. Statistically significant cell survival was determined with Student t test and analysis of variance. Results: Cell death was associated mainly with exposure to acetaminophen, was slightly potentiated when combined with hydromorphone, and was partially prevented by L-carnitine. Exposure to hydrocodone or hydromorphone alone failed to kill either cochlear hair cells or HEI-OC1 cells. Conclusion: Our findings point to acetaminophen, rather than hydrocodone, as the primary cytotoxic agent. Hydrocodone, however, may work synergistically with acetaminophen, increasing the damage to auditory cells. These findings are an important first step toward understanding the mechanism of acetaminophen/hydrocodone ototoxicity and may lead to future treatment strategies for hearing loss from ototoxic medications.",
author = "Yorgason, {Joshua G.} and Kalinec, {Gilda M.} and Luxford, {William M.} and Warren, {Frank M.} and Federico Kalinec",
year = "2010",
month = "6",
doi = "10.1016/j.otohns.2010.01.010",
language = "English (US)",
volume = "142",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse

T2 - Evidence from two parallel in vitro mouse models

AU - Yorgason, Joshua G.

AU - Kalinec, Gilda M.

AU - Luxford, William M.

AU - Warren, Frank M.

AU - Kalinec, Federico

PY - 2010/6

Y1 - 2010/6

N2 - Objective: Acetaminophen/hydrocodone, a commonly used analgesic preparation, has been linked to rapidly progressing sensorineural hearing loss in human patients. The cellular and molecular mechanisms underlying the ototoxic effects of this drug combination are currently unknown, but are usually associated with high doses of hydrocodone. This study was aimed at identifying the specific agent responsible for hearing loss from toxic killing of cochlear sensory cells. Study Design: Dose-response study. Setting: University laboratory and private research facility. Subjects and Methods: Math1 green fluorescent protein neonatal mouse cochlear cultures as well as a mouse auditory cell line (HEI-OC1) were exposed in vitro to different concentrations of acetaminophen, hydromorphone (the active metabolite of hydrocodone), and the micronutrient L-carnitine, either alone or combined. Using fluorescent and light microscopy, we quantified the sensory hair cells from a 600-μm basal segment before and after treatment. Acetaminophen/hydrocodone-induced apoptosis of HEI-OC1 was evaluated by caspase 3-activation studies. Statistically significant cell survival was determined with Student t test and analysis of variance. Results: Cell death was associated mainly with exposure to acetaminophen, was slightly potentiated when combined with hydromorphone, and was partially prevented by L-carnitine. Exposure to hydrocodone or hydromorphone alone failed to kill either cochlear hair cells or HEI-OC1 cells. Conclusion: Our findings point to acetaminophen, rather than hydrocodone, as the primary cytotoxic agent. Hydrocodone, however, may work synergistically with acetaminophen, increasing the damage to auditory cells. These findings are an important first step toward understanding the mechanism of acetaminophen/hydrocodone ototoxicity and may lead to future treatment strategies for hearing loss from ototoxic medications.

AB - Objective: Acetaminophen/hydrocodone, a commonly used analgesic preparation, has been linked to rapidly progressing sensorineural hearing loss in human patients. The cellular and molecular mechanisms underlying the ototoxic effects of this drug combination are currently unknown, but are usually associated with high doses of hydrocodone. This study was aimed at identifying the specific agent responsible for hearing loss from toxic killing of cochlear sensory cells. Study Design: Dose-response study. Setting: University laboratory and private research facility. Subjects and Methods: Math1 green fluorescent protein neonatal mouse cochlear cultures as well as a mouse auditory cell line (HEI-OC1) were exposed in vitro to different concentrations of acetaminophen, hydromorphone (the active metabolite of hydrocodone), and the micronutrient L-carnitine, either alone or combined. Using fluorescent and light microscopy, we quantified the sensory hair cells from a 600-μm basal segment before and after treatment. Acetaminophen/hydrocodone-induced apoptosis of HEI-OC1 was evaluated by caspase 3-activation studies. Statistically significant cell survival was determined with Student t test and analysis of variance. Results: Cell death was associated mainly with exposure to acetaminophen, was slightly potentiated when combined with hydromorphone, and was partially prevented by L-carnitine. Exposure to hydrocodone or hydromorphone alone failed to kill either cochlear hair cells or HEI-OC1 cells. Conclusion: Our findings point to acetaminophen, rather than hydrocodone, as the primary cytotoxic agent. Hydrocodone, however, may work synergistically with acetaminophen, increasing the damage to auditory cells. These findings are an important first step toward understanding the mechanism of acetaminophen/hydrocodone ototoxicity and may lead to future treatment strategies for hearing loss from ototoxic medications.

UR - http://www.scopus.com/inward/record.url?scp=77952289507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952289507&partnerID=8YFLogxK

U2 - 10.1016/j.otohns.2010.01.010

DO - 10.1016/j.otohns.2010.01.010

M3 - Article

VL - 142

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 6

ER -